MARKET

XTNT

XTNT

Xtant Medical
AMEX

Real-time Quotes | Nasdaq Last Sale

0.5310
+0.0009
+0.17%
Closed 14:04 05/26 EDT
OPEN
0.5500
PREV CLOSE
0.5301
HIGH
0.5500
LOW
0.5300
VOLUME
4.72K
TURNOVER
1.58K
52 WEEK HIGH
2.380
52 WEEK LOW
0.4800
MARKET CAP
46.36M
P/E (TTM)
-6.5637
1D
5D
1M
3M
1Y
5Y
Xtant Medical Holdings, Inc. Common Stock Q1 EPS $(0.03) Vs. $0.00 YoY, Sales $13.00M Miss $14.02M Estimate
Xtant Medical Holdings, Inc. Common Stock (AMEX:XTNT) reported quarterly losses of $(0.03) per share. The company reported quarterly sales of $13.00 million which missed the analyst consensus estimate of $14.02 million
Benzinga · 05/05 12:21
Xtant Medical GAAP EPS of -$0.03, revenue of $13M
Xtant Medical press release (NYSE:XTNT): Q1 GAAP EPS of -$0.03. Revenue of $13M (+3.7% Y/Y).
Seekingalpha · 05/05 12:02
-- Earnings Flash (XTNT) XTANT MEDICAL Reports Q1 Revenue $13M
MT Newswires · 05/05 08:13
BRIEF-Xtant Medical Appoints Scott Neils As Chief Financial Officer
reuters.com · 05/02 13:34
Xtant Medical Names Scott Neils as CFO
MT Newswires · 05/02 11:47
Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022
BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financ...
GlobeNewswire · 04/28 12:30
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022
BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and...
GlobeNewswire · 03/15 12:00
Xtant Medical Holdings, Inc. Common Stock Q4 EPS $(0.03) Down From $(0.01) YoY, Sales $13.97M Miss $14.02M Estimate
Xtant Medical Holdings, Inc. Common Stock (AMEX:XTNT) reported quarterly losses of $(0.03) per share. This is a 200 percent decrease over losses of $(0.01) per share from the same period last year. The company reported
Benzinga · 03/08 12:19
More
No Data
Learn about the latest financial forecast of XTNT. Analyze the recent business situations of Xtant Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average XTNT stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
High1.000
Average1.000
Low1.000
Current 0.5310
EPS
Actual
Estimate
-2.78-2.09-1.39-0.70
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q1 2018
Institutional Holdings
Institutions: 14
Institutional Holdings: 11.86M
% Owned: 13.59%
Shares Outstanding: 87.31M
TypeInstitutionsShares
Increased
4
22.60K
New
1
15
Decreased
2
5.68K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.54%
Healthcare Equipment & Supplies
+0.56%
Key Executives
Chairman/Director
Jeffrey Peters
President/Chief Executive Officer/Director
Sean Browne
Chief Financial Officer
Scott Neils
Other
Kevin Brandt
Director
Michael Eggenberg
Director
Matthew Rizzo
Independent Director
John Bakewell
Independent Director
Robert McNamara
No Data
No Data
About XTNT
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on designing, developing, and commercializing portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its Orthobiologics Products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoWrap and 3Demin. Its Spinal Implant Products include Cervical products, such as Certex Spinal Fixation System and Spider Cervical Plating System, and Thoracolumbar products, such as Axle Interspinous Fusion System, Silex Sacroiliac Joint Fusion System, Xpress Minimally Invasive Pedicle Screw System and Fortex Pedicle Screw System, and Interbody Products, such as Calix, Axle-X Interspinous Fusion System, Irix-C Cervical Integrated Fusion System and Irix-A Lumbar Integrated Fusion System.

Webull offers kinds of Xtant Medical Holdings Inc stock information, including AMEX:XTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XTNT stock methods without spending real money on the virtual paper trading platform.